Clinical Trials Logo

Filter by:
NCT ID: NCT05530941 Completed - Suicide Clinical Trials

Online Suicide Prevention Campaign Aimed at Men

Start date: February 3, 2022
Phase: N/A
Study type: Interventional

This study aims to examine whether the online suicide prevention campaign for men could increase openness about emotions and help-seeking behavior, and decrease hopelessness and adherence to traditional gender norms concerning self-reliance among men. The effectiveness of the campaign will be evaluated in adult men using a pre-post questionnaire study design.

NCT ID: NCT05527756 Completed - Scar Clinical Trials

Evaluation of the Cosmetic Outcomes of Totally Endoscopic Cardiac Surgery

SCARMICS
Start date: October 21, 2022
Phase:
Study type: Observational

Totally endoscopic cardiac surgery (TECS) is considered to have aesthetic advantages over conventional median sternotomy due to the smaller incisions. Most research regarding TECS focuses on clinical outcomes instead of cosmetic consequences. Following surgery, postoperative scarring is unavoidable and may negatively affect the patient's physical and emotional well-being. Therefore, this study aims to investigate the cosmesis after TECS.

NCT ID: NCT05527249 Completed - Healthy Aging Clinical Trials

Evaluation of a Dietary Supplementation Combining Proteins and Pomegranate Extracts in Older People

Delicens2021
Start date: December 24, 2021
Phase: N/A
Study type: Interventional

The objective of this safety study is to evaluate the safety of a combination of proteins and pomegranate extracts in healthy subjects aged 65 years or more after 21 days of supplementation.

NCT ID: NCT05526976 Completed - Clinical trials for Pain, Chronic Post-Surgical

PERIoperative Holistic RIsk Factor SCreening in the Prevention of Persistent Pain

PERISCOPEcare
Start date: December 22, 2022
Phase:
Study type: Observational

Assessment and management for improved wellbeing after elective surgery (PERISCOP³E-Care) Diagnostic assessment tool evaluation and cut-off determination for participation in a transmural perioperative care program

NCT ID: NCT05525364 Completed - Clinical trials for Diabetes Mellitus Risk

Hyperglycaemia In Childhood Hematologic Malignancies

DIAB-ONCO
Start date: June 20, 2019
Phase:
Study type: Observational

BACKGROUND/AIM: Secondary forms of diabetes are often understudied and underdiagnosed in children and adolescents with cancer. The objectives of this cohort study were to study the incidence and risk factors for hyperglycaemia in leukaemia and lymphoma patients. METHODS: The investigators retrospectively collected 15 years of data from paediatric patients treated for acute lymphoblastic leukaemia (ALL), Hodgkin's lymphoma (HL), and non-Hodgkin's lymphoma (NHL) immediately at cancer diagnosis. They studied risk factors for hyperglycaemia in univariate and multivariate analyses.

NCT ID: NCT05525195 Completed - Clinical trials for Congenital Heart Disease

Influence of Preop Fibrinogen on Blood in Pediatric Cardiac Surgery

Start date: September 17, 2022
Phase:
Study type: Observational

Fibrinogen plays an important role in the coagulation cascade. Low levels of preoperative fibrinogen have been associated in adults with higher blood and transfusion requirements during surgery. Guidelines from the European Society of Anesthesiology and Intensive Care recommends fibrinogen substitution based on viscoelastic tests in adult cardiac surgery. Cardiopulmonary bypass results in a profound hemodilution and dilution of all coagulation factors. This is especially true in children where the priming volume of the cardiopulmonary bypass circuit is much higher compared to the patient's weight than in adults. Cardiopulmonary bypass generates high levels of tissue plasminogen activator resulting in a hyperfibrinolysis, further lowering fibrinogen levels. The aim of this retrospective study is to explore a possible relationship between preoperative fibrinogen levels and perioperative blood loss, as well as transfusion requirements in children undergoing cardiac surgery.

NCT ID: NCT05525143 Completed - Clinical trials for Postpartum Hemorrhage

Postpartum Hemorrhage: Incidence and Risk Factors

Start date: October 10, 2022
Phase:
Study type: Observational

Postpartum hemorrhage(PPH) is a major cause of maternal morbidity and mortality across the world. Incidence of PPH varies in the literature from 2 to 10%, most recent studies find around 10% of PPH and 2% of severe PPH. In this study, the incidence of PPH in the maternal ward of the CHU Brugmann will be analyzed. This is a tertiary maternal ward with a high proportion of high risk pregnancies with around 3000 admissions per year. Primary aim of this study is to evaluate the epidemiology of PPH in the CHU Brugmann, incidence and possible underlying causes will be identified and compared to the current literature. A data mining technique will be used to construct a prediction model for PPH.

NCT ID: NCT05522517 Completed - Healthy Clinical Trials

A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4

Start date: August 22, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to characterize the delayed-type hypersensitivity (DTH) response at the site of Candin intradermal injection in the presence of a targeted immune pathway inhibitor.

NCT ID: NCT05522036 Completed - Actinic Keratoses Clinical Trials

Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®

Dermaris-35
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This clinical study aims aims to evaluate the clinical outcomes of SDL-PDT (simulated daylight Photodynamic Therapy) using the Dermaris in patients treated for AK lesions of the scalp at our medical dermatology center using only 35 minutes low-intensity light exposure.

NCT ID: NCT05518708 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test How Different Doses of BI 3032950 Are Tolerated

Start date: September 27, 2022
Phase: Phase 1
Study type: Interventional

The main objectives of this trial are to investigate safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BI 3032950 in healthy male subjects following intravenous (Part A) or subcutaneous (Part B) administration of single rising doses.